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Physical frailty is an age-associated syndrome of decreased reserve leading to vulnerability to physio-
logical stressors and associated with negative outcomes. The underlying structural brain abnormalities of
physical frailty are unclear. We investigated the association between brain volume, cortical brain infarcts,
and physical frailty. In this multicenter study, 214 nondemented participants were classified as frail (n ¼
32), prefrail (n ¼ 107), or nonfrail (n ¼ 75) based on the Fried frailty phenotype. The associations be-
tween frailty and brain volumes and cortical brain infarcts were investigated by linear or logistic
regression analyses. Participants in the frail group showed a lower total brain volume (19.67 mL [95%
confidence interval 37.84 to 1.50]) and lower gray matter volume (12.19 mL [95% confidence in-
terval 23.84 to 0.54]) compared to nonfrail participants. Frailty was associated with cortical brain
infarcts [frail 16% [n ¼ 5], prefrail 11% [n ¼ 12], and nonfrail 3% [n ¼ 2]). Reduced total brain volume and
gray matter volume and increased cortical brain infarcts seem therefore to be part of the structural
substrate of the physical frailty phenotype.
 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Frailty is defined as an age-associated biological syndrome of
decreased reserve that leads to a vulnerability to physiological
stressors (Clegg et al., 2013; Fried et al., 2001). Frail individuals have
an increased risk of adverse events, such as hospitalization, falls,
institutionalization, and complications after surgery including
postoperative delirium (Brown et al., 2016; Fried et al., 2001). Frailty
is most often described using the physical frailty phenotype (Buta
et al., 2016; Fried et al., 2001). This phenotype is assessed with 5
frailty components: slowness, weakness, exhaustion, weight loss,Care, Radiology, Heidelber-
31 88 7550850; fax: þ31 88
t).
Inc. This is an open access article uand a low level of activity (Fried et al., 2001). A combination of 3 or
more of these components classifies an individual as frail.
Previous studies showed that physical frailty is associated with
an increased risk of cognitive decline and dementia (Avila-funes
et al., 2012; Buchman et al., 2014; Solfrizzi et al., 2013). These
findings may suggest that neurodegenerative or neurovascular
changes are the structural substrate of the physical frailty pheno-
type. However, only few small studies have assessed the underlying
structural brain magnetic resonance imaging (MRI) correlates of
physical frailty. These studies have shown that signs of neurode-
generative or neurovascular changes, that is, lower global or
regional brain volume, a higher number of cerebral microbleeds,
and a higher burden of white matter hyperintensities of presumed
vascular origin (WMH), were related to frailty in older individuals
(Avila-funes et al., 2012, 2017; Chen et al., 2015; Chung et al., 2016;
Del Brutto et al., 2016; Jung et al., 2014; Newman et al., 2001; Siejka
et al., 2017). These studies were however limited to community-nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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dividuals. Knowledge on the biological basis and development of
physical frailty could lead to strategies to prevent dependence and
eventually reduce the burden on an economic, societal, and indi-
vidual level. To date, it is unknown if brain alterations are already
present in prefrail individuals. Furthermore, the association be-
tween cortical brain infarcts and physical frailty has never been
investigated.
The aim of the present study was to investigate differences in
brain volumes, WMH, and cortical brain infarcts in physical frail,
prefrail, and nonfrail older nondemented individuals who were
scheduled for elective surgery. In addition, we studied the relation
between these brain markers and individual frailty components.
2. Methods
2.1. Study design and participants
This investigation is part of the BioCog consortium study: an
ongoing multicenter prospective cohort study performed in the
Charité Universitätsmedizin Berlin and the University Medical
Center Utrecht. The general aim of the BioCog study is to identify
determinants of perioperative neurocognitive disorders (Winterer
et al., 2018). For the BioCog study, participants were included
whowere (1) scheduled for major elective surgery of a minimum of
60minutes, (2) at least 65 years of age, (3) able to undergo cognitive
tests (no blindness, deafness, neurological or psychiatric diseases)
and MRI scanning, and (4) had a MinieMental State Examination
(MMSE) score of 24 or higher. The present study uses data from the
first n ¼ 400 participants of the BioCog consortium study. All par-
ticipants signed an informed consent form, and all procedures were
approved by the medical ethics committee of both centers under
ethical approval number EA2/092/14 (Berlin) and 14-469 (Utrecht).
2.2. Procedure
All participants were invited before surgery for a visit that
included questionnaires, a frailty assessment, and an MRI scan.
Trained researchers collected data on age, gender, body mass index
(BMI), diabetes, smoking, and history of cardiovascular events. All
participants were assessed with the MMSE (Folstein et al., 1975) to
determine preoperative cognitive status. An MMSE score of 24 or
higher was considered as absence of severe dementia. The Amer-
ican Society of Anesthesiologists classification was assessed in a
preoperative interview by an anesthesiologist (in training) (Dripps
et al., 1961).
2.3. Frailty assessment
Frailty was assessed by trained researchers based on a modified
version of the Fried frailty phenotype by Rockwood et al. and con-
sisted of 5 frailty components: slowness, weakness, exhaustion,
weight loss, and a low level of activity (Fried et al., 2001; Rockwood
et al., 2007); see Supplementary Table A for a detailed description of
these components. Participants who had a combination of 3 or more
components were considered frail, participants who had a combi-
nation of 1 or 2 components were considered prefrail, and partici-
pants who had none of these components were considered nonfrail.
2.4. MRI scans
Participants were scanned on a Siemens Magnetom TrioTim
MRI scanner (Berlin) or a Philips Achieva 3T MRI scanner
(Utrecht). The MRI scanning protocol was standardized and con-
sisted of a 3-dimensional (3D) T1-weighted sequence (voxelsize ¼1.0  1.0  1.0 mm3; Berlin: 3D T1 magnetization-prepared
rapid acquisition gradient echo sequence, repetition time [TR]/
echo time [TE] ¼ 2500/4.77 ms; Utrecht: TR/TE ¼ 7.9/4.5 ms) and
a fluid-attenuated inversion recovery (FLAIR) sequence (Berlin:
TR/TE/inversion time ¼ 4800/388/1800 ms; voxel size ¼ 0.49 
0.49  1.00 mm3; Utrecht: TR/TE/inversion time ¼ 4800/125/
1650 ms; voxel size ¼ 1.11  1.11  0.56 mm3).
2.5. MRI processing steps and analysis
A robust approach to brain segmentation of multicenter data
was used (Heinen et al., 2016; Mendrik et al., 2015). 3D FLAIR im-
ages were registered to the 3D T1-weighted images by using sta-
tistical parametric mapping software (SPM12, Wellcome Institute
of Neurology, University College London, UK, http://www.fil.ion.ucl.
ac.uk/spm/doc/), running on Matlab R2013a (Mathworks, Natick,
MA, USA).WMH segmentations were performed on the FLAIR scans
by the lesion prediction algorithm (Schmidt, 2017) as implemented
in the Lesion Segmentation Toolbox version 2.0.15 (www.statistical-
modeling.de/lst.html) for SPM12. All resultingWMH segmentations
were visually checked for segmentation errors by trained re-
searchers (I.M.J.K., and E.A.) and in doubt by a radiologist (J.B.) with
10 years of experience in brain segmentation. WMH segmentations
were thresholded on a 0.5 probability, and WMH volumes were
calculated using the Lesion Segmentation Toolbox. Lesion filling
was performed on the 3D T1-weighted images by using the WMH
segmentations. The resulting “lesion filled” 3D T1-weighted images
were subsequently segmented in the CAT12 toolbox for SPM12
(Gaser and Dahnke, Jena University Hospital, Departments of Psy-
chiatry and Neurology, http://www.neuro.uni-jena.de/cat/index.
html#About). This resulted in segmentations of gray matter,
white matter, and cerebrospinal fluid. Intracranial volume (ICV),
total brain volume, gray matter volume, white matter volume, and
cerebrospinal fluid volume were calculated by the SPM12 option
“tissue volumes.” All scans were checked by a neuroradiologist (J.B.)
for presence of cortical brain infarcts and major artifacts that might
hinder accurate segmentations. Subsequently, all brain tissue seg-
mentations were visually checked for segmentation errors (e.g.,
registration errors, wrong classification of tissue) by a trained
researcher (I.M.J.K.). All cases that contained errors were discussed
in a consensus meeting with an expert neuroradiologist (J.B.). All
final decisions on exclusion of MRI data were made in this
consensus meeting. All scans that contained cortical brain infarcts
over 1.5 cm were excluded from the WMH and brain volume
analysis because of segmentation errors. We have used the
threshold of 1.5 cm based on the standards for reporting vascular
changes on neuroimaging (STRIVE) criteria for large subcortical
infarcts (Wardlaw et al., 2013). Brain surfaces were estimated by a
fully automated method that estimates cortical thickness and the
reconstruction of the central surface in 1 step (Gaser and Dahnke,
2012). To allow intersubject analysis, a spherical map was plotted
and images were smoothed by a 15-mm Gaussian kernel.
2.6. Statistical analysis
Demographic variables were compared between the 3 groups
(frail, prefrail, and nonfrail) by a one-way ANOVA or chi-square test
depending on the type of variable. For analysis of brain volumes,
participants with cortical brain infarcts over 1.5 cm were excluded.
To study differences in brain volumes (total brain volume, gray
matter volume, white matter volume, and WMH volume) between
frail, prefrail, and nonfrail participants, linear regression analyses
were performed adjusted for age, gender, ICV, and study center.
Analyses of WMH volume were additionally corrected for vascular
risk factors (hypertension, hypercholesterolemia, smoking, BMI,
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of the difference in presence of cortical brain infarcts over 1.5 cm
between frail, prefrail, and nonfrail participants, logistic regression
analyses were performed with the presence of a cortical brain
infarct as the dependent variable, adjusted for age, gender, and
study center. Analyses of brain volume differences and WMH dif-
ferences per frailty component were performed by linear regression
analyses corrected for age, gender, ICV, and study center. Presence
of cortical brain infarcts was analyzed by a logistic regression
analysis corrected for age, gender, and study center. All regression
analyses of global brain volumes, WMH, and cortical brain infarcts
were performed by using IBM SPSS version 21.
For analysis of cortical thickness differences between frail,
prefrail, and nonfrail participants, a linear regression model was
implemented in CAT12 and SPM12, with age, gender, and center as
covariates. All cortical thickness analyses were family-wise error
corrected and thresholded at p < 0.05. A cluster was considered
significant at a minimal amount of 86 vertices, based on the ex-
pected number of voxels per cluster.
3. Results
Of the initial 400 included participants in the BioCog study, 300
completed the preoperative MRI scanning protocol. Of these par-
ticipants, 20 had to be excluded because of a brain tumor, previous
trauma, MRI artifacts, or an incomplete MRI scanning protocol (see
Fig. 1). Furthermore, 66 participants had one or moremissing frailty
components and were thus excluded. This resulted in inclusion of
214 participants (mean age 72.4 years [SD: 4.9 years]; 37% female)
in the present study (see Fig. 1). In total, 32 participants (15%) were
classified as frail (3 or more frail components), 107 participants
(50%) were classified as prefrail (1 or 2 frail components), and 75
participants (35%) were classified as nonfrail (no frail components).
Frail participants were older [F(2,211)¼3.98, p < 0.05; planned
contrasts revealed that frail and prefrail participants were signifi-
cantly older than nonfrail participants {t(211)¼2.42, p < 0.05} andTable 1
Demographics
Total (N ¼ 214) Frail
Age 72.4  4.9 74.7
Female gender 80 (37%) 19 (5
MMSE 29 (28, 30) 28 (2
Center
Utrecht 74 (35%) 13 (4
Berlin 140 (65%) 19 (5
ASA score (n ¼ 211)*
I 12 (6%) 0 (0
II 134 (64%) 18 (5
III 65 (31%) 13 (4
Vascular risk factorsa
Diabetes 24 (11%) 4 (1
BMI 27 (24, 29) 29 (2
Hypertension 128 (60%) 22 (6
Hyperlipidemia 54 (25%) 10 (3
Current smoker 27 (13%) 2 (6
Self-reported previous cardiovascular events 6 (3%) 2 (6
Frailty components
Slowness 52 (24%) 25 (7
Weakness 63 (29%) 22 (6
Weight loss 14 (7%) 4 (1
Exhaustion 48 (22%) 23 (7
Mobility 82 (38%) 30 (9
Data represent n (percentage), mean  SD, or the median (interquartile range). A one-w
comparison of 3 groups was performed for categorical data.
* In preoperative ASA scores, 2 values were missing; therefore, a percentage of n ¼ 21
body mass index; MMSE, MinieMental State Examination; SD, standard deviation.
a In vascular risk factors, 3 values were missing; therefore, a percentage of n ¼ 211 par
cortical brain infarcts.that frail participants were significantly older than prefrail partic-
ipants {t(211)¼2.21, p < 0.05}], more often female [c2(2)¼7.90, p <
0.05], and had higher preoperative American Society of Anesthe-
siologists scores [c2(4)¼12.39, p < 0.05] compared to prefrail and
nonfrail participants (see Table 1 for demographics). The frailty
groups showed no differences in vascular risk factors. Patients with
cortical brain infarcts over 1.5 cm (n ¼ 19) were excluded from the
brain volume analysis due to segmentation errors. The de-
mographics of the brain volume analysis group after exclusion of
participants with cortical brain infarcts were comparable to the
original group (for demographics of the brain volume analysis
group, see Supplementary Table B).
3.1. Brain volumes and frailty
Table 2 shows the analyses on the association between total
brain volume, gray matter volume, white matter volume, WMH
volume, and frailty (see Supplementary Table B). Participants in the
frail group showed a lower total brain volume (19.67 mL [95%
confidence interval {CI} 37.84, 1.50]) and lower gray matter
volume (12.19 mL [95% CI 23.84, 0.54]) compared to partici-
pants in the nonfrail group. Participants in the frail group further
showed a lower total brain volume (22.40 mL [95%
CI 40.38, 4.41]) and lower gray matter volume (12.26 mL [95%
CI 23.09, 1.43]) compared to participants in the prefrail group.
No significant differences were found between the prefrail and
nonfrail group in total brain volume (1.16 mL [95 % CI 10.78,
13.11]), gray matter volume (0.43 (95% CI 8.11, 7.25)), white
matter volume (1.59 [95% CI 7.09, 10.27]), andWMH volume (0.32
[95% CI0.21, 0.84]) (see Table 2). A largerWMH volumewas found
in the frail group (9.53  13.13 mL) compared to the nonfrail group
(3.36  3.43 mL), but this difference was not statistically significant
(0.45 [95% CI 0.25, 0.93]) (see Table 2). Secondary analyses with
additional adjustment for vascular risk factors (hypertension, hy-
percholesterolemia, smoking, BMI, history of cardiovascular events,
and diabetes) showed an unchanged, nonsignificant association(n ¼ 32) Prefrail (n ¼ 107) Nonfrail (n ¼ 75) p-value
 5.4 72.3  5.0 71.6  4.5 0.020
9%) 37 (35%) 24 (32%) 0.019
7, 29) 29 (28, 30) 29 (28, 30) 0.021
0.11
1%) 42 (39%) 19 (25%)
9%) 65 (61%) 56 (75%)
0.015
%) 4 (4%) 8 (11%)
8%) 64 (60%) 53 (71%)
2%) 38 (36%) 14 (19%)
3%) 12 (12%) 8 (12%) 0.22
6, 33) 26 (24, 29) 27 (24, 28) 0.42
9%) 66 (62%) 40 (53%) 0.11
1%) 30 (28%) 14 (19%) 0.09
%) 15 (14%) 10 (13%) 0.46
%) 2 (2%) 2 (3%) 0.04
8%) 27 (25%) 0 (0%)
9%) 41 (38%) 0 (0%)
3%) 10 (8%) 0 (0%)
2%) 25 (23%) 0 (0%)
4%) 52 (49%) 0 (0%)
ay ANOVA comparison of 3 groups was performed on continuous data. A chi-square
2 participants was calculated.Key: ASA, American Society of Anesthesiologists; BMI,
ticipants was calculated. Previous cardiovascular events include previous stroke and
Fig. 1. Flowchart representing the included participants. MRI, magnetic resonance imaging.
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1.04], p ¼ 0.05; see Table 2). Analysis of cortical thickness showed a
lower global cortical thickness in frail participants compared to
prefrail and nonfrail participants. However, no association between
regional cortical thickness and physical frailty was found as no
clusters remained significant after family-wise error correction for
multiple comparisons and cluster size.3.2. Cortical brain infarcts and frailty
In total, 19 participants (9%) had cortical brain infarcts over
1.5 cm (see Table 3). The infarct prevalence was associated with
frailty status: frail (16%; n ¼ 5), prefrail (11%; n ¼ 12), and nonfrail
(3%; n ¼ 2). One of the participants with a cortical brain infarct had
reported a previous cardiovascular event (a transient ischemicTable 2
Brain volumes and regression analyses of frail, prefrail, and nonfrail participants
Total brain volume Gray matter volume
Brain volumes
Frail 1024.78  100.72 556.64  55.66
Prefrail 1047.10  103.58 567.88  51.89
Nonfrail 1060.47  110.22 572.45  57.92
Regression analyses
Frail versus nonfrail 19.67 (37.84, 1.50)a 12.19 (23.84, 0.54)a
Frail versus prefrail 22.40 (40.38, 4.41)a 12.26 (23.09, 1.43)a
Prefrail versus nonfrail 1.16 (10.78, 13.11) 0.43 (8.11, 7.25)
Brain volumes are in mL and are represented as mean SD. Regression analysis adjusted f
presented with a 95% confidence interval. WMH volumes were multiplied by 100 and natu
are regression beta coefficients that were additionally corrected for cardiovascular risk f
events, and smoking).
Key: BMI, body mass index; SD, standard deviation; WMH, white matter hyperintensitie
a p-value < 0.05.
b p-value ¼ 0.06.attack); this participant was classified as frail. All other participants
therefore had silent cortical infarcts. None of these participants has
reported a previous myocardial infarction. Although participants in
the frail group hadmore cortical brain infarcts compared to those in
the nonfrail group, this did not reach statistical significance (OR ¼
4.14 [95% CI 0.63, 27.40]; see Table 3). Participants in the prefrail
group showed a higher odds ratio of having a cortical brain infarct
compared to participants in the nonfrail group (OR ¼ 4.66 [95% CI
1.00, 21.73]).3.3. Brain volumes, cortical brain infarcts, and individual frailty
components
Analyses on individual frailty components across groups and
brain volumes, and cortical brain infarcts are shown in Table 4. InWhite matter volume WMH volume WMH volume model 2
468.15  55.56 9.53  13.13
479.22  59.55 5.81  7.25
488.01  58.20 3.36  3.43
7.48 (20.72, 5.75) 0.45 (0.25, 0.93)b 0.52 (0.01, 1.04)
10.14 (24.05, 3.77) 0.32 (0.21, 0.84) 0.42 (0.12, 0.95)
1.59 (7.09, 10.27) 0.11 (0.23, 0.44) 0.15 (0.21, 0.50)
or age, gender, intracranial volume, and study center. Regression beta coefficients are
ral logetransformed before performing regression analyses. WMH volumes model 2
actors (hypertension, hypercholesterolemia, BMI, diabetes, previous cardiovascular
s of presumed vascular origin.
Table 3
The presence of cortical brain infarcts in relation to physical frailty
Cortical brain infarcts and physical frailty
Presence of cortical brain infarcts
Frail 5 (16%)
Prefrail 12 (11%)
Nonfrail 2 (3%)
Logistic regression analyses
Frail versus nonfrail 4.14 (0.63, 27.40)
Frail versus prefrail 1.48 (0.45, 4.84)
Prefrail versus nonfrail 4.66 (1.00, 21.73)a
Data on presence of cortical brain infarcts over 1.5 cm are presented as n (per-
centage). Logistic regression analysis adjusted for age, gender, and study center.
Corrected odds ratios are presented with a 95% confidence interval.
a p-value ¼ 0.05.
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bined and assessed per component. Most frailty components were
associated with brain volumes and occurrence of cortical brain in-
farcts, but these associations did not reach statistical significance
(see Table 4).4. Discussion
We investigated differences in brain volumes and cortical brain
infarcts between frail, prefrail, and nonfrail older individuals in a
large group of older individuals. We showed that frail individuals
had more neurodegenerative and neurovascular abnormalities
compared to prefrail and nonfrail individuals. Frail individuals had a
significantly lower total brain volume and lower gray matter vol-
ume and showed a trend for more cortical brain infarcts and a
higher WMH volume compared to nonfrail individuals. Frail in-
dividuals showed a lower global cortical thickness compared to
prefrail and nonfrail individuals; however, no regional clusters of a
lower cortical thickness were found. Individual frailty components
showed a relation with a lower global gray matter volume, but this
did not reach statistical significance. Furthermore, prefrail in-
dividuals had more cortical brain infarcts compared to nonfrail
individuals.
Quantification of global and regional brain atrophy as an MRI
marker for neurodegenerative diseases is widely performed in
research on cognitive impairment and dementia (Mak et al., 2015;
Verlinden et al., 2017). However, only few studies have performed
these analyses in relation to frailty (Chen et al., 2015; Del Brutto
et al., 2016). These studies included a low number of frail in-
dividuals and thus combined prefrail and frail individuals in 1
group, possibly reducing the contrast between groups (Chen et al.,
2015). Furthermore, the method of determining frailty differed
between studies. Some studies have used the physical frailty
phenotype and others the Edmonton Frail Scale, which combinesTable 4
Brain volume changes and presence of cortical brain infarcts per frailty component for t
Total brain volume
(N ¼ 195)
Gray matter volume
(n ¼ 195)
W
(n
Slowness b ¼ 12.60 (25.91, 0.70) b ¼ 5.63 (14.02, 2.75) b ¼
Weakness b ¼ 8.08 (20.75, 4.59) b ¼ 4.39 (12.34, 3.57) b ¼
Weight loss b ¼ 18.18 (39.84, 3.47) b ¼ 9.12 (22.74, 4.50) b ¼
Exhaustion b ¼ 2.94 (16.56, 10.68) b ¼ 2.93 (11.47, 5.61) b ¼
Mobility b ¼ 4.27 (15.80, 7.25) b ¼ 5.23 (12.43, 1.97) b
Linear regression analysis on the association between individual frailty components and t
frailty component adjusted for age, gender, intracranial volume, and study center. Regre
Key: WMH, white matter hyperintensities of presumed vascular origin.
a Logistic regression analysis on cortical brain infarcts adjusted for age, gender, and st
b There were no participants who fulfilled the criterion for weight loss and had a cortphysical and cognitive frailty scores (Fried et al., 2001; Rolfson et al.,
2006). This does not allow direct comparison of results between
these studies. In line with the results of Chen et al., we showed an
association between physical frailty and a lower gray matter vol-
ume (Chen et al., 2015). We additionally showed an association
between physical frailty and a lower total brain volume and gray
matter volume. Chen et al. previously showed that distinct patterns
of regional (mainly cerebellar) gray matter volume changes were
associated with individual frailty components and with physical
frailty. Our results confirm their findings by showing an association
of frailty and of all individual components with global gray matter
volume changes. However, in contrast to previous findings, analysis
of regional cortical thickness showed no significant regional dif-
ferences in cortical thickness, which is possibly due to the hetero-
geneous nature of physical frailty.
WMHs are common in older individuals and are an MRI marker
of cerebral small vessel disease (Wardlaw et al., 2013). WMHs are
related to cognitive decline and physical deterioration such as gait
problems (De Laat et al., 2011; Inzitari et al., 2009; Van Dijk et al.,
2008). To date, only few studies have investigated the association
between WMH and physical frailty (Avila-funes et al., 2017; Chen
et al., 2015; Chung et al., 2016; Del Brutto et al., 2016; Siejka
et al., 2017), of which only 2 studies have assessed WMH quanti-
tatively (Avila-funes et al., 2017; Chen et al., 2015). The association
between physical frailty and WMH is unclear, as 3 previous studies
found no association between WMH and frailty (Chen et al., 2015;
Chung et al., 2016; Del Brutto et al., 2016), and only one study did
find an association (Avila-funes et al., 2017; Siejka et al., 2017). We
found a trend for an association between increased WMHs in the
frail versus the nonfrail group. Because of the large variability in
WMH volumes between individuals, future studies with larger
patient groups are needed to prove a potential association between
WMHvolume and physical frailty. Alternatively, otherMRImethods
that can investigate the structural integrity of the white matter,
such as diffusion tensor imaging, may be performed to detect dif-
ferences in white matter integrity between frail, prefrail, and
nonfrail (Avila-funes et al., 2017).
Cortical brain infarcts are an MRI marker of large vessel disease
and are associated with cognitive decline (Aggarwal et al., 2012).
Only one study has specifically explored the association between
brain infarcts and physical frailty (Newman et al., 2001). In this
study, the presence of brain infarcts greater than 3 mm was asso-
ciated with physical frailty; however, the authors did not distin-
guish different infarct types according to underlying
pathophysiology (i.e., cortical, subcortical, or lacunar brain infarcts)
(Newman et al., 2001). Another investigation that assessed physical
and cognitive frailty in a combined way showed that brain infarcts
occurred more frequently in frail compared to prefrail and nonfrail
individuals (Del Brutto et al., 2016). Our investigation is the first to
assess the association between a physical frailty state and thehe total group
hite matter volume
¼ 195)
WMH volume
(n ¼ 195)
Cortical brain infarcts
(n ¼ 234)a
6.97 (16.77, 2.83) b ¼ 0.23 (0.14, 0.60) OR ¼ 2.28 (0.84, 6.23)
3.69 (13.01, 5.63) b ¼ 0.01 (0.34, 0.36) OR ¼ 1.31 (0.48, 3.59)
9.06 (25.01, 6.88) b ¼ 0.24 (0.36, 0.84) -b
0.01 (10.01, 9.99) b ¼ 0.36 (0.02, 0.73) OR ¼ 2.02 (0.73, 5.56)
¼ 0.96 (7.51, 9.42) b ¼ 0.01 (0.33, 0.31) OR ¼ 1.78 (0.68, 4.65)
otal brain volume, gray matter volume, white matter volume, and WMH volume per
ssion beta coefficients are presented with a 95% confidence interval.
udy center. Adjusted odds ratios are presented with a 95% confidence interval.
ical brain infarct over 1.5 cm.
I.M.J. Kant et al. / Neurobiology of Aging 70 (2018) 247e253252presence of cortical brain infarcts. Our results confirm the relation
between physical frailty and cerebral infarcts, which was shown in
previous studies (Del Brutto et al., 2016; Newman et al., 2001). In
addition, we have shown an association between a physical pre-
frailty state and the presence of cortical brain infarcts and a
nonsignificant increase in presence of cortical brain infarcts be-
tween prefrail and frail participants.
A limitation of our study may be between-center differences in
MRI-based brain volumes. To minimize the effect of these possible
between-center differences, MRI protocols were made comparable,
and we used a brain segmentation pipeline that is relatively robust
for between-center differences (Heinen et al., 2016). We also used
“center” as a covariate in the analyses. This approachminimized the
between-center differences in brain volumes. Another limitation
may be that all participants were scheduled for major elective
surgery. Therefore, we cannot rule out a possible association be-
tween the reason for elective surgery (e.g., total hip replacement)
and components of physical frailty. Finally, our study is limited by
its cross-sectional design. Therefore, we are unable to assess
whether smaller brain volume measures were already present
before development of the frailty phenotype. A strength of our
study is the inclusion of a large group of participants, which
enabled the separate analysis of frail, prefrail, and nonfrail in-
dividuals. This allowed us to study prefrail individuals separately,
which is a group that has received almost no previous attention.
Furthermore, the physical frailty phenotype is the most frequently
usedmethod to classify frailty in research and clinical practice (Buta
et al., 2016). Therefore, use of this method enables comparison of
our results with recent literature and gives us insight into the un-
derlying mechanism of this clinical concept.
In conclusion, individuals with physical frailty showed lower
global brain volumes and lower global gray matter volumes
compared to prefrail and nonfrail individuals. Individuals with
physical frailty and prefrailty also showed more cortical brain in-
farcts compared to nonfrail individuals. These brain changes could
be the underlying substrate of the physical frailty phenotype.Disclosure statement
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